VerifyNow® IIb/IIIa Test
Glycoprotein (GP) IIb/IIIa inhibitors such as ReoPro® and Integrilin® are fast acting and powerful inhibitors of platelet aggregation that prevent the binding of platelets to fibrinogen.
The VerifyNow IIb/IIIa Test utilizes a thrombin receptor activating peptide as an agonist to maximally stimulate the platelet and determine the level of platelet function. Research shows that patients’ platelet response to weight-based dosing varies, and the VerifyNow IIb/IIIa Test provides physicians with an accurate assessment of platelet blockade in response to IIb/IIIa inhibitors in less than five minutes from the time of sample collection.
INTENDED USE
The VerifyNow IIb/IIIa Test is a semi-quantitative, whole blood platelet function test used to measure glycoprotein (GP) IIb/IIIa receptor blockade in patients treated with abciximab or eptifibatide. The VerifyNow IIb/IIIa Test results should be interpreted in conjunction with other clinical and laboratory data available to the clinician.